Skip to main content
FDA Updates
Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma
Michael K.K. Wong, MD, PhD, FRCPC, Anthony Jarkowski III, PharmD, BCOP
Read More
Letters to the Editor
Impact of Pharmacists’ Intervention in Altering Prescribing Patterns for the Treatment of VTE in Patients with Cancer
Read More
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Original Research
Early Access to Investigational Agents through the National Cancer Institute’s Treatment Referral Center
Tali M. Johnson, PharmD, BCOP, Matthew J. Boron, RPh
Read More
Original Research
Impact of Pharmacists’ Interventions on Prescribing Patterns for the Treatment of VTE in Patients with Cancer
Vikki M. Steward, PharmD, Hind Hamid, PharmD, Kimberly Hooker, PharmD
Read More
Supportive Care
Chemotherapy-Induced Diarrhea: Options for Treatment and Prevention
Elizabeth A. Koselke, PharmD, Shawna Kraft, PharmD, BCOP
Read More
Testicular Germ-Cell Tumors: A History of “If You Don’t Cure the First Time, Try, Try Again”
Read More
Medication Therapy Management in the Outpatient Cancer Center
Read More
Effects of a Reduced Dose of Pegfilgrastim on the Incidence of Febrile Neutropenia and Bone Pain: A Retrospective Analysis
Lew Iacovelli, BS, PharmD, BCOP, CPP, Richard Harms, PharmD, RPh, May Mo, MS
Read More
Page 188 of 199
Results 1871 - 1880 of 1986